Ozanimod hydrochloride

• CAT Number: I034107
• CAS Number: 1618636-37-5
• Molecular Formula: C23H25ClN4O3
• Molecular Weight: 440.93
• Purity: 98%
• Synonyms: Ozanimod hydrochloride; Ozanimod HCl
• Target: LPL Receptor
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile;hydrochloride
• InChI: InChI=1S/C23H24N4O3.ClH/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28;/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3;1H/t20-;/m0./s1
• InChIKey: HAOOCAKHSFYDBU-BDQAORGHSA-N
• SMILES: CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N.Cl

Ozanimod hydrochloride（Cat No.:I034107）is an oral medication used to treat multiple sclerosis (MS) and ulcerative colitis (UC). It is a selective sphingosine-1-phosphate (S1P) receptor modulator, which works by altering the activity of certain immune cells, reducing their ability to attack the central nervous system in MS or causing inflammation in UC. By modulating immune cell migration, ozanimod helps reduce symptoms, flare-ups, and disease progression in MS and UC patients. It is marketed under the brand name Zeposia and is typically prescribed after other treatments fail.